APA (7th ed.) Citation

Le Joncour, A., Régnier, P., Maciejewski-Duval, A., Charles, E., Barete, S., Fouret, P., . . . Saadoun, D. (2023). Type-4 Phosphodiesterase (PDE4) Blockade Reduces Neutrophil activation in Behçet's disease. Arthritis & rheumatology (Hoboken, N.J.).

Chicago Style (17th ed.) Citation

Le Joncour, Alexandre, et al. "Type-4 Phosphodiesterase (PDE4) Blockade Reduces Neutrophil Activation in Behçet's Disease." Arthritis & Rheumatology (Hoboken, N.J.) 2023.

MLA (9th ed.) Citation

Le Joncour, Alexandre, et al. "Type-4 Phosphodiesterase (PDE4) Blockade Reduces Neutrophil Activation in Behçet's Disease." Arthritis & Rheumatology (Hoboken, N.J.), 2023.